ORGO
Organogenesis Holdings Inc
NASDAQ: ORGO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.35
+2.17% today
Updated 2026-04-30
Market cap
$307.45M
P/E ratio
15.93
P/S ratio
0.55x
EPS (TTM)
$0.15
Dividend yield
—
52W range
$2 – $7
Volume
1.4M
Organogenesis Holdings Inc (ORGO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2001 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.40M | $-10.19M | $-562233.00 | $-586604.00 | $-60.74M | $-33.53M | $5.47M | $61.98M | $24.86M | $30.92M | $14.21M | $-10.31M |
| Capital expenditures | $977576.00 | $510000.00 | $1.36M | $2.43M | $1.86M | $6.23M | $17.68M | $31.22M | $33.90M | $24.36M | $10.03M | $14.15M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $459000.00 | $473000.00 | $919000.00 | $1.07M | $936000.00 | $1.66M | $3.86M | $6.55M | $9.00M | $10.58M | $13.30M |
| Free cash flow | $-2.37M | $-10.70M | $-1.92M | $-3.01M | $-62.60M | $-39.76M | $-12.21M | $30.76M | $-9.04M | $6.55M | $4.18M | $-24.46M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | $0.00 | — | — | — | — | $57.90M | — | $1.46M | $648000.00 | — | $1.80M | $11.37M |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | $24.44M | $29.72M | $-11.24M | — | — | — |